CRISPR Breakthroughs
The first CRISPR therapy has received FDA approval, marking a significant milestone in gene editing medicine. This groundbreaking treatment for sickle cell anemia and beta thalassemia showcases the potential for programmable medicines and demonstrates a rapid progression from discovery to approval in just over ten years. With this achievement, the pathway for future CRISPR therapies may become shorter and more efficient, offering hope to patients in need of innovative treatments.In this clip
From this podcast
The a16z Podcast
Big Ideas in 2024: Programming Medicine’s Final Frontier with Jorge Conde
Related Questions